Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Unsupervised analysis of thorax CT datasets Marian Himstedt University of Luebeck NLST Jan 18, 2022 NLST-870
Federated Validation of Lung Nodule Detection Algorithms. Brian Ayers Gesund AI NLST Jan 18, 2022 NLST-869
Pan-cancer gene-environment interaction studies jianbo Tian School of Health Public Wuhan University PLCO Jan 18, 2022 PLCO-900
BMI and the risk of renal cell carcinoma : a case control study Benjamin Chung Stanford University PLCO Jan 18, 2022 PLCO-896
Radiomic analysis of Chest radiographs for prediction of lung cancer outcomes Anant Madabhushi Emory University PLCO Jan 18, 2022 PLCOI-887
Interpretable AI prediction of prostate tumor staging Matthias Weidemüller Universität Heidelberg PLCO Jan 18, 2022 PLCO-897
Association of dietary carrot intake with colorectal cancer incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial zongze Jiang West China Fourth Hospital PLCO Jan 18, 2022 PLCO-899
The influence of biological factors and environmental exposure on the occurrence and prognosis of various cancers and the construction of prediction models Xiaorong Yang Qilu Hospital of Shandong University PLCO Jan 13, 2022 PLCO-890
Development and evaluation of combined cancer screening strategies for high-risk populations of Prostate, Lung, Colorectal and Ovarian Cancers Huang Yubei Tianjin Medical University Cancer Institute and Hospital PLCO Jan 13, 2022 PLCO-895
Clinically Applicable Deep Learning Pipeline for Diagnosis of Mediastinal Neoplasms Hengrui Liang The First Affiliated Hospital of Guangzhou Medical University NLST Jan 12, 2022 NLST-868
Pulmonary Adenocarcinoma of Low Malignant Potential Eric Burks Boston University School Of Medicine NLST Jan 7, 2022 NLST-867
Threshold quantile regression models with applications to PSA data Eun Ryung Lee Sungkyunkwan University PLCO Jan 7, 2022 PLCO-893
Modeling risk for lung cancer using trans-ancestry polygenic risk score, blood biomarkers, and lifestyle behaviors Meng Zhu Nanjing Medical University PLCO Jan 7, 2022 PLCO-892
The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with colon cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. Percy Guzman Percy Guzman PLCO Jan 7, 2022 PLCO-882
Chest Radiograph And Pathologic Phenotype For Biological Age Prediction Using Deep Learning – Training and Validation in Chinese Patients Varut Vardhanabhuti The University of Hong Kong PLCO Jan 5, 2022 PLCOI-820
Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO Summer Han Stanford University PLCO Jan 5, 2022 PLCO-886
Development of deep learning frameworks based on pathology images for biomarker development Jennifer Beane Trustees of Boston University PLCO Jan 5, 2022 PLCOI-881
Chest Radiograph and Computed Tomography Phenotyping For Longevity Prediction Using Deep Learning – Training and Validation in Chinese Patients Varut Vardhanabhuti The University of Hong Kong NLST Jan 5, 2022 NLST-865
Low-dose CT scan screening for lung cancer: To establish an accurate predictive model through radiomics methods and optimize follow-up CT screening strategies Yin Cai The Hong Kong Polytechnic University NLST Dec 30, 2021 NLST-863
The impact of hormone replacement therapy on cancer Zhaoyu Li University of Western Australia PLCO Dec 30, 2021 PLCO-883